ALSTON & BIRD LLP for THE METROHEALTH SYSTEM
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); COVID-19 regulatory changes in general; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act, The Consolidated Appropriations Act of 2021, the Families First Coronavirus Response Act (FFCRA), and the Coronavirus Aid, Relief and Economic Security (CARES) Act - issues impacting hospital financing, Medicaid DSH, telehealth expansion, Provider Relief Funds; H.R.266/P.L. 116-139, the Health Care Enhancement Act - provisions related to Public Health and Social Services Emergency Fund; support for issues regarding recognition of uncompensated care costs and addressing social determinants of health in the Medicaid and Medicare populations; H.R.7292 - The COVID-19 Hospital Forgiveness Act; support of telehealth policies, including for audio-only telehealth services; H.R.5376 - Build Back Better Act, policies concerning Medicare graduate medical education (GME); H.R.7053/S.3792 - acute hospital care at home waiver flexibility; policy proposals to address mental and physical/medical comorbidities of beneficiaries in the Medicare/Medicaid programs; H.R.1868/Pub. L. No. 117-7, To prevent across-the-board direct spending cuts, and for other purposes/Medicare sequester; in general - protecting access to physician services for Medicare beneficiaries per preventing reductions resulting from Medicare sequestration, Statutory PAYGO, and reduction in Medicare conversion factor for CY2023; H.R.2617, the Consolidated Appropriations Act, 2023.
| Lobbyist | Covered position, as disclosed |
|---|---|
| Y. BRIAN LEE | — |
| MICHAEL PARK | — |
| MARK RAYDER | — |
| EMILY A SHAW | — |
| MARILYN K YAGER | — |
Health Issues HCR
Provider status for pharmacists; implementation of the No Surprises Act, P.L. 116-260; sustainability of safety net health systems; social determinants of health; promoting coordinated care; FCCs COVID-19 Telehealth Program; support of telehealth policies, including for audio-only telehealth services; Hill-Burton funding for front line safety net hospitals in H.R.5376; within Inflation Reduction Act, P.L. 117-169, impact of pharmaceutical pricing policies on 340B drug discount program; S.3799, PREVENT Pandemics Act (social determinants of health provisions); policy proposals to address mental and physical/medical comorbidities of beneficiaries in the Medicare/Medicaid programs; H.R.2617, the Consolidated Appropriations Act, 2023.
| Lobbyist | Covered position, as disclosed |
|---|---|
| Y. BRIAN LEE | — |
| MICHAEL PARK | — |
| MARK RAYDER | — |
| EMILY A SHAW | — |
| MARILYN K YAGER | — |
Budget/Appropriations BUD
Funding for senior housing development; H.R.2617, the Consolidated Appropriations Act, 2023.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK RAYDER | — |
Housing HOU
H.R.7990, Healthy Homes Act, concerning low-income housing tax credit reforms related to addressing social determinants of health; H.R.2617, the Consolidated Appropriations Act, 2023.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK RAYDER | — |
Taxation/Internal Revenue Code TAX
H.R. 7990, Healthy Homes Act, concerning low-income housing tax credit reforms related to addressing social determinants of health.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK RAYDER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.